# AKSO HEALTH GROUP (AHG)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AHG/

- Reporting holders: 11
- Reported value: $488.2K
- Shares held by institutions: 327,673 of 1,655,583,530 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $137.2K | 92,052 | 0.0% | 1 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $105.7K | 70,943 | 0.0% | 23 |
| [NORTHERN TRUST CORP](https://holderbook.com/funds/73124-northern-trust-corp/) | $76.6K | 51,403 | 0.0% | 3 |
| [SmartHarvest Portfolios, LLC](https://holderbook.com/funds/2066604-smartharvest-portfolios-llc/) | $66.7K | 44,755 | 0.0% | 3 |
| [JANE STREET GROUP, LLC](https://holderbook.com/funds/1595888-jane-street-group-llc/) | $61.6K | 41,360 | 0.0% | 2 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $22.3K | 14,973 | 0.0% | 12 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $15.0K | 10,064 | 0.0% | 4 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $1.4K | 963 | 0.0% | 1 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $1.1K | 739 | 0.0% | 1 |
| [HUNTINGTON NATIONAL BANK](https://holderbook.com/funds/49205-huntington-national-bank/) | $624 | 419 | 0.0% | 1 |
| [Caitong International Asset Management Co., Ltd](https://holderbook.com/funds/1963355-caitong-international-asset-management-co-ltd/) | $3 | 2 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 11 | $488.2K |
| Q1 2026 | 6 | $517.4K |
| Q4 2025 | 5 | $284.7K |
| Q3 2025 | 4 | $271.0K |
| Q2 2025 | 5 | $224.1K |
| Q1 2025 | 8 | $248.0K |
| Q4 2024 | 8 | $318.5K |
| Q3 2024 | 6 | $216.0K |
| Q2 2024 | 6 | $203.3K |
| Q1 2024 | 6 | $322.8K |
| Q4 2023 | 5 | $202.5K |
| Q3 2023 | 7 | $343.2K |